MSVMX Mutual Fund (Vitality Portfolio Class C) is managed by Morgan Stanley Investment Management. MSVMX expense ratio is 2.05%, holding 33 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2021-12-31.

MSVMX performance shows a YTD return of 0.78%. The 1-year return is 27.99%. MSVMX dividend yield stands at 0.58%, paid annually.

MSVMX top holdings include Argenx NV ADR (8.0%), Eli Lilly And Company (7.8%), Ascendis Pharma A/S - Adr Sedol Bv9G6B8 (5.5%), Nektar Therapeutics Class A (4.8%), Thermo Fisher Scientific Inc (4.3%). View all MSVMX holdings, sector breakdown, or dividend history.

MSVMX can be compared against other funds using the overlap calculator or side-by-side comparison tool. MSVMX alternatives are available via the screener, along with tax-loss harvesting opportunities.